Because No One is Immune to the Law
December 12, 2019 - Licensing + Commercial, Intellectual Property, Asia

Crossing Borders

China Patent Eligibility Update: Human Embryonic Stem Cells

Partner Janet Xiao, who leads the firm’s China Life Sciences Group, co-authored an article with associate Can Cui for Intellectual Property Magazine, titled “Crossing Borders,” which explores technology transfer opportunities emerging from import rules in China.

The authors note that Chinese companies are eager to bring foreign innovative technologies to China, and, despite trade tensions between the U.S. and China, cross-border technology transfers into China, especially in the life sciences area, have remained active. Janet and Can then breakdown how these technology transfers are being regulated through China’s technology import and export regulations (TIER), including how a recent amendment to TIER has impacted the space.